On November 26, 2018 Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer, reported that its management will provide a corporate update at the forthcoming Evercore ISI HealthCONx BioPharma, MedTools, and Devices Conference, and the BMO Capital Markets Prescriptions for Success Healthcare Conference (Press release, Molecular Templates, NOV 26, 2018, View Source [SID1234531657]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Evercore ISI HealthCONx – BioPharma, MedTools, & Devices Conference
Date: Wednesday, November 28
Time: 7:35 am Eastern Time
Location: Boston Harbor Hotel
Webcast: View Source

BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
Date: Wednesday, December 12
Time: 9:00 am Eastern Time
Location: The Mandarin Oriental, New York